Patents by Inventor Nadia Soussi-Yanicostas

Nadia Soussi-Yanicostas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES
    Publication number: 20210018518
    Abstract: Methods for the diagnosis and prognosis of neurodegenerative diseases, such as a Tauopathy or Alzheimer's disease, are described. Compositions and methods for the treatment of neurodegenerative diseases are also described.
    Type: Application
    Filed: March 12, 2020
    Publication date: January 21, 2021
    Inventors: Dulce PAPY-GARCIA, Minh Bao HUYNH, Nadia SOUSSI-YANICOSTAS, Rita VOZARI, Fernando SINERIZ, Constantin YANICOSTAS
  • Method of diagnosis, prognostic or treatment of neurodegenerative disease
    Patent number: 10324096
    Abstract: Methods for the diagnosis and prognosis of neurodegenerative diseases, such as Alzheimer's disease, are described. Compositions and method for the treatment of neurodegenerative diseases are also described.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: June 18, 2019
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS-EST CRETEIL VAL DE MARNE, SORBONNE UNIVERSITÉ, ICM-INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE, OTR3, ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS
    Inventors: Dulce Papy-Garcia, Minh Bao Huynh, Nadia Soussi-Yanicostas, Rita Vozari, Fernando Sineriz, Constantin Yanicostas
  • METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES
    Publication number: 20180045740
    Abstract: Methods for the diagnosis and prognosis of neurodegenerative diseases, such as a Tauopathy or Alzheimer's disease, are described. Compositions and methods for the treatment of neurodegenerative diseases are also described.
    Type: Application
    Filed: August 23, 2017
    Publication date: February 15, 2018
    Inventors: Dulce PAPY-GARCIA, Minh Bao HUYNH, Nadia SOUSSI-YANICOSTAS, Rita VOZARI, Fernando SINERIZ, Constantin YANICOSTAS
  • METHOD OF DIAGNOSIS, PROGNOSTIC OR TREATMENT OF NEURODEGENERATIVE DISEASES
    Publication number: 20160334421
    Abstract: Methods for the diagnosis and prognosis of neurodegenerative diseases, such as Alzheimer's disease, are described. Compositions and method for the treatment of neurodegenerative diseases are also described.
    Type: Application
    Filed: June 29, 2016
    Publication date: November 17, 2016
    Inventors: Dulce PAPY-GARCIA, Minh Bao HUYNH, Nadia SOUSSI-YANICOSTAS, Rita VOZARI, Fernando SINERIZ, Constantin YANICOSTAS
  • METHOD OF DIAGNOSIS, PROGNOSTIC OR TREATMENT OF NEURODEGENERATIVE DISEASES
    Publication number: 20140302510
    Abstract: The present invention relates to a method of diagnosis, prognostic or treatment of neurodegenerative diseases, in particular Alzheimer's disease.
    Type: Application
    Filed: October 15, 2012
    Publication date: October 9, 2014
    Inventors: Dulce Papy-Garcia, Minh Bao Huynh, Nadia Soussi-Yanicostas, Rita Vozari, Fernando Sineriz, Constantin Yanicostas
  • Therapeutic composition comprising the KAL protein and use of the KAL protein for the treatment of retinal, renal, neuronal and neural injury
    Publication number: 20070037736
    Abstract: KAL protein is identified the active agent in a therapeutic composition for treatment of injury to nerve tissue, including spinal cord tissue, as well as support of treatment for renal grafts. Additionally, therapeutic treatment of renal injury, and kidney transplantation and renal surgery, is effected by administration of KAL protein. The therapeutic agent may be administered locally, or intravenously. Retinal disorders may be similarly treated.
    Type: Application
    Filed: June 29, 2006
    Publication date: February 15, 2007
    Applicants: INSTITUT PASTEUR, Centre National De La Recherche Scient.
    Inventors: Christine Petit, Nadia Soussi-Yanicostas, Jean-Pierre Hardelin, Catherine Sarailh, Genevieve Rougon, Renaud Legouis, Olivier Ardouin, Jean-Claude Mazie
  • Therapeutic composition comprising the KAL protein and use of the KAL protein for the treatment of retinal, renal, neuronal and neural injury
    Publication number: 20020123467
    Abstract: KAL protein is identified the active agent in a therapeutic composition for treatment of injury to nerve tissue including spinal cord tissue, as well as support of treatment for renal grafts. Additionally, therapeutic treatment of renal injury, and kidney transplantation and renal surgery, is effected by administration of KAL protein. The therapeutic agent may be administered locally, or intravenously. Retinal disorders may be similarly treated.
    Type: Application
    Filed: April 11, 2002
    Publication date: September 5, 2002
    Applicant: INSTITUT PASTEUR
    Inventors: Christine Petit, Nadia Soussi-Yanicostas, Jean-Pierre Hardelin, Catherine Sarailh, Genevieve Rougon, Renaud Legouis, Olivier Ardouin, Jean-Claude Mazie